1968P The clinical effect of concurrent oncogenic gene mutations in BRAF p.(V600E)-mutated NSCLC treated with dabrafenib and trametinibP. Meng,B. Koopman,K. Kok,A. ter Elst,E. Schuuring,L.C. van Kempen,W. Timens,T.J.N. Hiltermann,H.J.M. Groen,A. van den Berg,A.J. van der WekkenAnnals of Oncology(2020)引用 0|浏览52暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要